Movetis sales and marketing update

Movetis launched Resolor prucalopride in Belgium to treat chronic constipation in women not receiving adequate relief from laxatives. The company said it launched the serotonin (5-HT4) receptor agonist prior to receiving reimbursement approval from Belgian health care insurance authority, but is preparing to file for reimbursement status. The public price for a 28-tablet pack is €75.50 ($96.70) and €61.60 ($78.90) for the 2 and 1 mg dose, respectively. The recommended dose for Resolor is a 2 mg tablet given once daily. ...